Amanda Feilding — also known as the Countess of Wemyss and March — is the drug policy reformer who has sponsored many of the “headline-grabbing studies” that exploring how many recreational drugs — such as cannabis, LSD, and MDMA — could be effective in “treating everything from depression to post-traumatic stress disorder and nicotine addiction,” reports Zing Tsjeng.
For decades, Feilding has believed in the life-changing potential of drugs, and her think tank and NGO continues to sponsor and support into the therapeutic effects of such “recreational drugs.” At first, many thought she was just a “mad” aristocrat with too much time and money on her hands.
Yet, in 2014, Feilding’s Beckley Foundation sponsored and supported a significant study at Johns Hopkins in which psilocybin (the compound found in magic mushrooms) was given to longtime smokers to see if it helped with nicotine addiction.
“The results were staggering: 80 percent of the participants successfully stayed away from cigarettes after six months, compared to the 30 percent success rate of conventional treatments for smoking,” notes Tsjeng.
“[Psychedelics] just give one the strength to carry out a decision that is common sense,” Fielding told Broadly.